Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03558178
Other study ID # JS-CT-2018-03
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 6, 2018
Est. completion date December 5, 2019

Study information

Verified date January 2020
Source Jaseng Medical Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A multi-center randomized controlled trial assessing the comparative effectiveness and cost-effectiveness of Doin (conduction exercise) with acupuncture for chronic neck pain


Description:

A multi-center randomized controlled, parallel, assessor-blinded full-scale trial will be conducted based on the results of the pilot study to evaluate the comparative clinical effectiveness and cost-effectiveness of Doin (conduction exercise) with acupuncture for chronic neck pain patients compared to acupuncture alone as assessed using pain, functional disability, health-related quality of life, economic evaluation, and safety measures.


Recruitment information / eligibility

Status Completed
Enrollment 124
Est. completion date December 5, 2019
Est. primary completion date January 8, 2019
Accepts healthy volunteers No
Gender All
Age group 19 Years to 70 Years
Eligibility Inclusion Criteria:

- Neck area pain duration of 6 months or longer

- Current Numeric Rating Scale (NRS) for neck area pain of 5 or higher

- Patients who have agreed to voluntarily participate in the clinical trial and given written informed consent

Exclusion Criteria:

- Patients diagnosed with serious pathology(s) which may cause neck pain (e.g. malignant tumor, spinal infection, inflammatory spondylitis)

- Progressive neurologic deficit or severe neurologic symptoms (e.g. cauda equina syndrome, progressive muscle weakness)

- Pathologies of non-spinal or soft tissue origin or high severity which may cause neck or radiating arm pain (e.g. malignant tumor, spinal infection, inflammatory spondylitis, fibromyalgia, rheumatic arthritis, gout)

- Other chronic diseases which may interfere with treatment effect or interpretation of results (e.g. cardiovascular disorder, renal disease, diabetic neuropathy, dementia, epilepsy)

- Current intake of steroids, immunosuppressant medicine, psychiatric medicine or other medication which may interfere with treatment results

- Patients considered unsuitable or unsafe to receive acupuncture (e.g. patients with hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine intake, severe diabetes with high risk of infection, severe cardiovascular diseases)

- Patients who were treated with invasive interventions such as acupuncture or injections, or with medicine that may potentially influence pain such as NSAIDs (nonsteroidal antiinflammatory drugs) within the past week

- History of cervical surgery within the past 3 months

- Pregnancy or plans of pregnancy

- Severe psychopathy

- Participation in other clinical studies

- Inability to give written informed consent

- Other reasons rendering trial participation inappropriate as judged by the researchers

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Doin with acupuncture
Doin (conduction exercise) will be performed with the needles in situ by increasing the cervical range of motion (rotation) with physician guidance and isometric resistance exercise as indicated. Doin sessions will be conducted 2 times a week for 5 weeks (total 10 sessions).
Device:
Acupuncture
Acupuncture will be performed with manual stimulation (needle twirling) to evoke de-qi sensation. Acupuncture sessions will be conducted 2 times a week for 5 weeks (total 10 sessions).

Locations

Country Name City State
Korea, Republic of Bucheon Jaseng Hospital of Korean Medicine Bucheon Gyeonggi
Korea, Republic of Haeundae Jaseng Hospital of Korean Medicine Busan
Korea, Republic of Daejeon Jaseng Hospital of Korean Medicine Daejeon
Korea, Republic of Jaseng Hospital of Korean Medicine Seoul
Korea, Republic of Kyung Hee University Oriental Medicine Hospital at Gangdong Seoul

Sponsors (2)

Lead Sponsor Collaborator
Jaseng Medical Foundation Kyung Hee University Hospital at Gangdong

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference between visual analogue scale (VAS) of neck pain for the past 3 days at 5 weeks post-baseline and baseline VAS uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain' and 'worst pain possible' (labels may vary by study). Scores are recorded in millimeters with a total range of 0-100 millimeters. Week 5 post-baseline (screening)
Secondary Difference between visual analogue scale (VAS) of radiating arm pain for the past 3 days at each timepoint and baseline, respectively VAS uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain' and 'worst pain possible' (labels may vary by study). Scores are recorded in millimeters with a total range of 0-100 millimeters. Week 1, 2, 3, 4, 5, 6 post-baseline (screening)
Secondary Difference between numeric rating scale (NRS) of neck pain for the past 3 days at each timepoint and baseline, respectively In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'. Week 1, 2, 3, 4, 5, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Difference between numeric rating scale (NRS) of radiating arm pain for the past 3 days at each timepoint and baseline, respectively In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'. Week 1, 2, 3, 4, 5, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Difference between Neck Disability Index (NDI) at each timepoint and baseline, respectively The NDI evaluates functional impairment and is a 10-item questionnaire developed to assess the level of disability due to neck pain. Each item is graded into 6 levels, each representing a score of 0-5. Higher scores indicate greater limitation relating to neck pain. Week 1, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Difference between Northwick Park Neck Pain Questionnaire (NPQ) at each timepoint and baseline, respectively The NPQ evaluates functional impairment for the past 3 days in this study and is a patient reported outcome of subjective neck pain and pain reduction. The NPQ is a 9-item questionnaire developed to assess the level of disability due to neck pain. Each item is graded into 5 levels, each representing a score of 0-4. Higher scores indicate greater limitation relating to neck pain. Week 1, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Patient Global Impression of Change (PGIC) PGIC grades the level of subjective improvement into 7 levels (1, very much improved; 2, much improved; 3, slightly improved; 4, no change; 5, slightly worse; 6, much worse; and 7, very much worse). Week 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Physical examination Pain upon movement in cervical range of motion (ROM) will be assessed. Week 1, 6 post-baseline (screening)
Secondary Difference between the 5 level version of EuroQol-5 Dimension (EQ-5D-5L) at each timepoint and baseline, respectively EQ-5D is a tool developed for health-related quality of life (HRQoL) assessment, and is widely used in the health care sector. Scores range from -1, 'health worse than death' to 1, 'perfect health'. EQ-5D-5L has 5 dimensions covering current health status and functionality: mobility (M), self care (SC), usual activities (UA), pain/discomfort (PD), and anxiety/depression (AD), to be rated out of 5 grades (1, no problem; 2, slight problem; 3, some/moderate problem; 4, severe problem; 5, extreme problem). Week 1, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Difference between the EuroQol Visual Analogue Scale (EQ-VAS) at each timepoint and baseline, respectively EQ-VAS uses a vertical 10cm line labeled at each end with scale anchors. EQ-VAS is used to indicate the patient's health state and patients are asked to mark a point that represents their health state between the anchors of 'worst health state' and 'best health state imaginable'. Scores are recorded in millimeters with a total range of 0-100 millimeters. Week 1, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Difference between the Short Form Health Survey 12 (SF-12) at each timepoint and baseline, respectively SF-12 is a simplified version of SF-36. SF-12 assesses health-related quality of life (HRQoL) across 8 domains with 1-2 items per domain: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health. Higher scores indicate better HRQoL. Week 1, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Economic evaluation (medical costs) Economic evaluation of medical costs will be performed to assess cost-effectiveness of the 2 groups. Week 1, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Economic evaluation (time-related costs) Economic evaluation of time-related costs will be performed to assess cost-effectiveness of the 2 groups. Week 2 post-baseline (screening)
Secondary Economic evaluation (lost productivity costs) Economic evaluation of lost productivity costs will be performed to assess cost-effectiveness of the 2 groups. Week 1, 2, 3, 4, 5, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Credibility and Expectancy Questionnaire The credibility and expectancy questionnaire will be used to assess treatment expectation on a 9-point Likert scale. Participants will be asked to select an answer to the following questions on their first visit of Week 1 (1='not at all'; and 5='somewhat'; to 9='very much'): "How much do you expect that treatment will alleviate your symptoms during the study period?" Week 1 post-baseline (screening)
Secondary Drug Consumption (drug type) The drug type of prescription intake for medicine or rescue medicine (acetaminophen) will be recorded. Week 1, 2, 3, 4, 5, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Drug Consumption (drug dose) The drug dose of prescription intake for medicine or rescue medicine (acetaminophen) will be recorded. Week 1, 2, 3, 4, 5, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Other treatments (treatment type) The type of other treatments received (e.g. physical therapy, injections) will be recorded. Week 1, 2, 3, 4, 5, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Other treatments (treatment frequency) The frequency of other treatments received (e.g. physical therapy, injections) will be recorded. Week 1, 2, 3, 4, 5, 6, Month 3, 6, 9, 12 post-baseline (screening)
Secondary Adverse events Physicians will monitor and record any unexpected or unintended patient reaction to Chuna or usual care at each visit. Adverse events (AEs) associated with Chuna will include, but not be limited to, AEs anticipated from previous reports of manual therapy, and will stay open to all possibilities taking into consideration other potential, unknown AEs. Week 1, 2, 3, 4, 5, 6, Month 3, 6, 9, 12 post-baseline (screening) (every visit)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06054672 - Subthreshold Stimulation on Chronic Low Neck Pain Myofascial Trigger Points N/A
Completed NCT04201379 - Determines of Quality of Life in Patients
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT06206343 - Telerehabilitation With Transcutaneous Electrical Nerve Stimulation Chronic Neck Pain: N/A
Not yet recruiting NCT06377995 - Effectiveness of an Intervention Plan Aimed at the Diaphragm in Chronic Non-specific Neck Pain N/A
Not yet recruiting NCT01200745 - Efficacy of Topical Capsaicin on Chronic Neck Pain N/A
Completed NCT00907049 - Association Between Neck Pain and Quality of Sleep N/A
Completed NCT04035018 - Effectiveness of Pharmacopuncture for Chronic Neck Pain N/A
Active, not recruiting NCT03702075 - Self-administered Program in Chronic Neck Pain N/A
Completed NCT06337916 - The Effect of Cervical Stabilization Exercises on the Cervical Proprioception in Patients With Chronic Neck Pain N/A
Completed NCT05229393 - Manual Therapy to the Cervical Spine and Diaphragm Combined With Breathing Reeducation Exercises, in nsCNP Patients N/A
Recruiting NCT00618878 - Electroacupuncture and Laser Therapy on Neck Pain N/A
Completed NCT03294785 - Comparative Effectiveness and Cost-effectiveness of Chuna Manual Therapy for Chronic Neck Pain N/A
Recruiting NCT06468904 - Efficacy of Cervical Stabilization Exercises on Hand Grip Strength in Chronic Myofascial Neck Pain N/A
Completed NCT04125901 - Pain Neuroscience Education and Exercise in High School Students With Chronic Idiopathic Neck Pain N/A
Completed NCT04630119 - Prospective Analysis of Quality of Life, Presenteeism, and Emotional Health Due to Chronic Neck Pain in Homemakers
Completed NCT03121859 - Analgesic Current Therapies for Chronic Neck Pain N/A
Recruiting NCT05605639 - Phrenic Nerve Infiltration in Neck Pain Phase 4
Not yet recruiting NCT05581446 - Pain Types and Pain Severity in Chronic Neck Pain
Enrolling by invitation NCT04136964 - Cross-cultural Adaptation and Validation of Arabic Version of COMI in Patients With Chronic Neck Pain